Kymera Therapeutics
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation.
7
Funding Rounds
$394.0m
Money raised
Overview
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Kymera Therapeutics has raised a total of $197m in funding over 7 rounds.
Key Insights:
- Kymera Therapeutics Series C round, March 2020: $102m
- Kymera Therapeutics Series B round, November 2018: $65m
- Kymera Therapeutics Series A round, October 2017: $30m
- Kymera Therapeutics Series A Funding Round October 2017: $30m
- Kymera Therapeutics Series B Funding Round November 2018: $65m
- Kymera Therapeutics Series C Funding Round March 2020: $102m
Kymera Therapeutics Series C round, March 2020
$102m
Kymera Therapeutics Series B round, November 2018
$65m
Kymera Therapeutics Series A round, October 2017
$30m
Kymera Therapeutics Series A Funding Round October 2017
$30m
Kymera Therapeutics Series B Funding Round November 2018
$65m
Kymera Therapeutics Series C Funding Round March 2020
$102m
Industries
Kymera Therapeutics is active in the following industries: